Alpha Tau Medical Ltd. (DRTS) — Dilution Risk Analysis

Current Snapshot

Alpha Tau Medical Ltd. (DRTS) has a DilutionWatch score of 30/10 and is classified as MEDIUM risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
88,009,737 Source
Public Float
47,482,208 Source
Float as % of Outstanding
54.0%

Dilution Risk Score

Score: 30/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

Recent filing forms in the source payload: EFFECT 1, F-3 1, 3 8.

FormFiledAccession
EFFECT 2026-05-01 9999999995-26-001447
F-3 2026-04-28 0001213900-26-048160
3 2026-03-18 0001213900-26-031124
3 2026-03-18 0001213900-26-031125
3 2026-03-18 0001213900-26-031126
3 2026-03-18 0001213900-26-031127
3 2026-03-18 0001213900-26-031128
3 2026-03-18 0001213900-26-031129
3 2026-03-18 0001213900-26-031130
3 2026-03-18 0001213900-26-031131

Dilution Risk Drivers

DriverStored ValueSource
Shelf registration capacity $300,000,000 Source
Cash runway 32 months Source
Three-year share count growth 26.32% Source

DilutionWatch Analysis

Risk Level
MEDIUM (Score: 30/10) Source
Cash Runway
32 months Source
Shelf Registration Capacity
$300,000,000 Source
Share Count Growth (3-Year)
26.32% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.